American Well Corp
AMWL NYSE Services-Business Services, Nec Financials FY2018βFY2025
What American Well Corp does
No business description yet.
- Legal name
- American Well Corp
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Feb 12, 2026
- Accession Β· CIK
- 0001193125-26-048776
0001393584
Revenue and margins
American Well Corp had $249M of revenue in fiscal 2025, down 2.0% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was β$66.0M in fiscal 2025, β26.5% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
American Well Corp returned β to shareholders in fiscal 2025. The diluted share count rose 7.0%.
Balance sheet
Cash, debt and the ratios that show how comfortably American Well Corp can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $746M | $539M | $372M | $228M | $182M |
| Current ratio | 5.8x | 5.5x | 4.8x | 2.8x | 3.4x |
| Quick ratio | 5.8x | 5.4x | 4.7x | 2.8x | 3.4x |
| Total assets | $1.4B | $1.2B | $590M | $436M | $324M |
| Total liabilities | $185M | $134M | $110M | $120M | $76.0M |
| Shareholders' equity | $1.2B | $1.1B | $464M | $305M | $236M |
| Net debt (β = net cash) | β | β | β | β | β |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β |
| F-score | β / 3 | β / 4 | 3 / 7 | 2 / 7 | 3 / 7 | 2 / 7 | 3 / 7 | 4 / 7 |
| Accruals ratio | β | β1.1% | β11.9% | β2.5% | β5.9% | β58.3% | β15.8% | β7.8% |
| Altman Z'' | β | β4.65 | 12.09 | 7.48 | 6.70 | β9.20 | β12.29 | β16.17 |
8 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $114M | $149M | $245M | $253M | $277M | $259M | $254M | $249M |
| Net interest income | β | β | β | β | $5.0M | $9.3M | $11.8M | $5.2M |
| Research and development | $36.3M | $53.9M | $84.4M | $107M | $138M | $106M | $86.1M | $72.9M |
| Operating income | β$55.1M | β$94.7M | β$227M | β$179M | β$276M | β$692M | β$218M | β$105M |
| Pretax income | β$52.3M | β$89.2M | β$226M | β$179M | β$270M | β$675M | β$210M | β$94.5M |
| Income tax | $0.0M | β$0.8M | $0.6M | β$5.4M | $0.1M | $3.9M | $2.8M | $0.4M |
| Net income | β$52.7M | β$87.2M | β$224M | β$176M | β$270M | β$675M | β$208M | β$95.7M |
| Diluted EPS | β$1.30 | β$2.12 | β$2.27 | β$0.69 | β$19.72 | β$47.50 | β$13.88 | β$5.96 |
| Diluted shares | 0.04B | 0.04B | 0.10B | 0.25B | 0.01B | 0.01B | 0.01B | 0.02B |
| Cash flow | ||||||||
| Cash from operations | β$74.0M | β$81.9M | β$112M | β$142M | β$192M | β$148M | β$127M | β$66.0M |
| Capital expenditure | $1.9M | $1.3M | $3.3M | $0.6M | $0.3M | $0.2M | $0.1M | $0.0M |
| Free cash flow | β$75.9M | β$83.2M | β$116M | β$142M | β$193M | β$149M | β$127M | β$66.0M |
| Depreciation and amortization | $5.3M | $7.8M | $10.2M | $16.1M | $26.2M | $31.5M | $33.0M | $34.0M |
| Stock-based compensation | $7.7M | $12.1M | $118M | $43.8M | $67.7M | $72.2M | $47.5M | $22.0M |
| Acquisitions | $64.4M | $45.8M | β | $157M | β | β | β | β |
| Balance sheet | ||||||||
| Cash and short-term investments | $48.0M | $178M | $1.0B | $746M | $539M | $372M | $228M | $182M |
| Current assets | β | $224M | $1.1B | $827M | $627M | $450M | $317M | $247M |
| Current liabilities | β | $107M | $121M | $142M | $114M | $93.8M | $111M | $73.2M |
| Inventory | β | $3.1M | $9.1M | $7.5M | $8.7M | $6.7M | $2.9M | $1.2M |
| Property and equipment, net | β | $2.7M | $3.8M | $2.2M | $1.0M | $0.6M | $0.4M | $0.2M |
| Goodwill | $127M | $194M | $194M | $443M | $435M | $0.0M | $0.0M | β |
| Intangible assets | β | $63.5M | $55.5M | $152M | $135M | $120M | $102M | $66.1M |
| Total assets | β | $500M | $1.4B | $1.4B | $1.2B | $590M | $436M | $324M |
| Total liabilities | β | $125M | $130M | $185M | $134M | $110M | $120M | $76.0M |
| Shareholders' equity | β$204M | β$307M | $1.2B | $1.2B | $1.1B | $464M | $305M | $236M |
| Margins | ||||||||
| Operating margin | β48.4% | β63.6% | β92.7% | β70.9% | β99.5% | β267.2% | β85.5% | β42.2% |
| EBITDA margin | β43.7% | β58.4% | β88.6% | β64.5% | β90.1% | β255.0% | β72.6% | β28.6% |
| Net margin | β46.2% | β58.6% | β91.5% | β69.8% | β97.6% | β260.6% | β81.8% | β38.4% |
| FCF margin | β66.6% | β55.9% | β47.2% | β56.2% | β69.5% | β57.3% | β50.1% | β26.5% |
| Net interest share of revenue | β | β | β | β | 1.8% | 3.6% | 4.6% | 2.1% |
| Returns | ||||||||
| Return on capital employed | β | β24.1% | β18.1% | β13.7% | β25.0% | β139.6% | β67.0% | β42.0% |
| Return on equity | β | β | β48.9% | β14.3% | β23.5% | β88.4% | β54.1% | β35.4% |
| Return on assets | β | β17.4% | β23.9% | β12.5% | β20.3% | β74.7% | β40.6% | β25.2% |
| Return on tangible equity | β | β | β23.0% | β27.4% | β54.8% | β196.3% | β102.4% | β56.5% |
| Growth | ||||||||
| Revenue growth | β | 30.6% | 64.8% | 3.1% | 9.7% | β6.5% | β1.8% | β2.0% |
| Share count change | β | 1.4% | 140.8% | 156.5% | β94.6% | 3.6% | 5.5% | 7.0% |
| Financial health | ||||||||
| Current ratio | β | 2.1x | 9.2x | 5.8x | 5.5x | 4.8x | 2.8x | 3.4x |
| Quick ratio | β | 2.1x | 9.1x | 5.8x | 5.4x | 4.7x | 2.8x | 3.4x |
| Capital allocation | ||||||||
| Capex / revenue | 1.7% | 0.9% | 1.4% | 0.2% | 0.1% | 0.1% | 0.0% | 0.0% |
| Stock comp / revenue | 6.7% | 8.2% | 48.3% | 17.3% | 24.4% | 27.9% | 18.7% | 8.8% |
| Quality scores | ||||||||
| Piotroski F-score | β | β | 3.0 | 2.0 | 3.0 | 2.0 | 3.0 | 4.0 |
| Altman Z'' | β | β4.7 | 12.1 | 7.5 | 6.7 | β9.2 | β12.3 | β16.2 |
| Accruals ratio | β | β1.1% | β11.9% | β2.5% | β5.9% | β58.3% | β15.8% | β7.8% |
Source: SEC EDGAR XBRL filings (CIK 0001393584). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.